Coloplast A/S

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 13/09/2024 BST			5-day change	1st Jan Change
941.80 ^DKK	+2.06%		+5.16%	+21.99%

08-26	COLOPLAST : Q3 24: Chronic care momentum makes up for urology pain
08-21	Jyske Bank Downgrades Coloplast to Hold, Trims PT	MT

Presentation Operator MessageOperator (Operator)Ladies and gentlemen, thank you for standing b...

This article is reserved for subscribers

To unlock the article, SUBSCRIBE!

Already a customer? Log In

Latest news about Coloplast A/S

COLOPLAST : Q3 24: Chronic care momentum makes up for urology pain	08-26
Jyske Bank Downgrades Coloplast to Hold, Trims PT	08-21	MT
Global markets live: Rio Tinto, GSK, Palo Alto, GM, Lowe's...	08-20
Coloplast Sticks to 2024 Guidance as Fiscal Third Quarter Revenue Beats, Profit Misses	08-20	MT
Transcript : Coloplast A/S, Nine Months 2024 Earnings Call, Aug 20, 2024	08-20
Coloplast's Fiscal Q3 Net Profit Flatlines; Revenue Rises	08-20	MT
Coloplast A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	08-20	CI
Coloplast A/S Re-Affirms Earnings Guidance for the Fiscal Year 2023/24	08-20	CI
Powell's Hint Hunt	08-19
AlphaValue/Baader Europe Downgrades Coloplast to Reduce, Trims PT	08-15	MT
Barclays Upgrades Coloplast to Overweight, Lifts PT	07-22	MT
Danske Bank Upgrades Coloplast to Buy from Hold	07-10	MT
Transcript : Coloplast A/S - Analyst/Investor Day	06-06
COLOPLAST : Multiple silver linings in spite of a soft Q2 24	05-15
European shares hit one-month high as earnings take centre stage	05-07	RE
European shares hit one-month high on upbeat earnings, rate-cut optimism	05-07	RE
Transcript : Coloplast A/S, H1 2024 Earnings Call, May 07, 2024	05-07
Coloplast Posts Higher Fiscal H1 Net Profit, Revenue	05-07	MT
Coloplast Strengthens Ostomy Care Portfolio with Three Significant Product Launches	05-07	CI
Coloplast A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-07	CI
Coloplast A/S Revises Earnings Guidance for the Fiscal Year 2023/24	05-07	CI
Coloplast A/S Announces Interim Dividend for the First Half of 2023/24, Payable on May 15, 2024	05-07	CI
Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024.	02-26	CI
COLOPLAST : Q1 24: Many more positives beyond the margin beat	02-14
Nordic Shares Moved Upward Friday; Kongsberg Gruppen Topped Leaders	02-09	DJ

Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).

Employees

16,019

Sector

Medical Equipment, Supplies & Distribution

Calendar

05/11/2024 - Q4 2024 Earnings Release

More about the company